Brief: Promore Pharma Q1 Operating Loss Narrows To SEK 7.1 Mln
May 27 (Reuters) - Promore Pharma AB PROMO.ST :
* INTERIM REPORT JANUARY – MARCH 2021
* Q1 OPERATING LOSS FOR PERIOD WAS MSEK -7.1 (-7.3)
Source text for Eikon: ID:nMFN8nmgFy
Further company coverage: PROMO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on PMD Device Solutions AB
See all newsBrief: PMD Device Solutions Files For Bankruptcy
Brief: PMD Device Solutions Q3 EBITDA Loss Widens To SEK 8.9 Mln
Brief: Pmd Device Solutions Completes Sale Of Coala Life Monitor
Brief: PMDS’ Largest Shareholder Requests EGM To Appoint New Non-Executive Directors
Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality